Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-6.14 Insider Own0.10% Shs Outstand395.60M Perf Week-6.01%
Market Cap94.13B Forward P/E13.89 EPS next Y17.13 Insider Trans- Shs Float395.29M Perf Month-6.90%
Income-2422.60M PEG- EPS next Q3.64 Inst Own87.60% Short Float1.49% Perf Quarter0.84%
Sales15.37B P/S6.12 EPS this Y23.00% Inst Trans-2.39% Short Ratio1.85 Perf Half Y-17.99%
Book/sh181.28 P/B1.31 EPS next Y22.38% ROA3.20% Target Price299.06 Perf Year-23.74%
Cash/sh1.28 P/C185.80 EPS next 5Y13.49% ROE6.00% 52W Range195.50 - 322.68 Perf YTD-23.86%
Dividend- P/FCF21.34 EPS past 5Y-50.40% ROI-1.30% 52W High-26.26% Beta0.73
Dividend %- Quick Ratio0.90 Sales past 5Y33.40% Gross Margin78.70% 52W Low21.70% ATR5.20
Employees31200 Current Ratio1.00 Sales Q/Q-77.20% Oper. Margin-17.50% RSI (14)36.56 Volatility2.81% 1.92%
OptionableYes Debt/Eq0.56 EPS Q/Q78.20% Profit Margin28.20% Rel Volume1.09 Prev Close236.31
ShortableYes LT Debt/Eq0.52 EarningsAug 08 BMO Payout0.00% Avg Volume3.17M Price237.93
Recom1.90 SMA20-5.31% SMA50-2.44% SMA200-10.25% Volume3,449,228 Change0.69%
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Apr-06-16Downgrade Mizuho Buy → Neutral $330 → $250
Mar-31-16Reiterated Canaccord Genuity Buy $340 → $320
Feb-23-16Reiterated Mizuho Buy $354 → $330
Feb-23-16Reiterated Deutsche Bank Buy $308 → $339
Feb-19-16Initiated Wells Fargo Outperform
Nov-24-15Reiterated Mizuho Buy $340 → $354
Aug-28-16 03:01PM  Allergan: An Undervalued Powerhouse
Aug-27-16 06:36PM  Here Are All The Big Biotech Mergers In 2016
04:17AM  Billionaire John Paulsons Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan at Insider Monkey
Aug-26-16 04:49PM  FTC spells out new concerns over generic drug mergers
12:02PM  FTC Details Concerns on Generic Drug Company Mergers
11:46AM  Bill Ackman: 'We made one very big mistake' with Valeant and lost big time at CNBC
10:15AM  ETFs with exposure to Allergan Plc : August 26, 2016
Aug-25-16 07:04PM  Elliott Management Added Allergan in 2Q16
04:09PM  Markets Right Now: Health care pulls stocks lower again
02:33PM  Teva Pharmaceutical Industries Ltd -- Moody's: Teva's Loss of Two Copaxone Patents is Credit Negative at Moody's
01:32PM  Specialty Pharma: Never Mind the Pricing Controversy, Fundamentals Will Win Out at Barrons.com
11:04AM  AstraZenecas Recent Product Developments
09:30AM  Allergan, Humana, Biogen: Billionaires Favorite Healthcare Stocks For Q3 at Insider Monkey
08:06AM  Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : August 25, 2016
Aug-24-16 05:11PM  Pfizer on buying spree with AstraZeneca antibiotics deal
12:00PM  Top 5 Shareholders of Allergan (AGN) at Investopedia
11:04AM  Performance of AstraZenecas RI&A Segment in 2Q16
10:43AM  David Einhorn Cashed Out of These 9 Stocks
10:27AM  Stocks edge lower as mining and materials companies slip
09:00AM  Apple, McDonalds, Yahoo: 5 Stocks Hedge Funds Were Getting Rid of During Q2 at Insider Monkey
07:01AM  Pfizer Picks Up AstraZeneca's Antibiotics Business
Aug-23-16 07:41PM  3 Stocks Billionaires Are Buying at Motley Fool
09:20AM  Blog Coverage Valeant Pharma Appoints New CEO
08:58AM  Pfizer Has Had A Busy M&A Year...Or Has It?
Aug-22-16 06:32PM  13F Filings: Thumbs Up Or Thumbs Down For Gladiators? at Forbes
04:05PM  Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise
01:24PM  [$$] Pfizer makes $14bn bet on cancer drugmaker Medivation at Financial Times
12:48PM  Carl Icahn Buys Allergan
11:46AM  Pfizer spends $14B on Medivation in cancer fight
11:04AM  Teva Pharmaceutical: A Successful Bond Financing Program in 2016
10:05AM  Allergan Makes an Eye-Opening Acquisition at Motley Fool
09:06AM  How Did Bristol-Myers Squibbs Oncology Segment Perform in 2Q16?
07:20AM  [$$] Pfizer agrees $14bn takeover of Medivation at Financial Times
06:53AM  EU mergers and takeovers (Aug 22) Reuters
Aug-20-16 08:34AM  9 Stocks Smart Investors Put Their Money in Last Quarter
Aug-19-16 07:25PM  Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN) at Investopedia
04:40PM  Actavis recalls diabetes drugs made by Durham-based Patheon at bizjournals.com
04:25PM  Allergan Upgraded As New Product Launch Could Drive Botox Sales
10:54AM  Top stocks for hedge funds
10:33AM  Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC
08:55AM  Top Analyst Upgrades and Downgrades: AK Steel, Allergan, ArcelorMittal, Symantec, Teck Resources, US Steel, Emerson, Hormel and More at 24/7 Wall St.
08:32AM  Allergan (AGN) Stock Rises, Mizuho Upgrades to 'Buy'
07:57AM  4 Stocks Carl Icahn Is Buying in 2016
07:56AM  Early movers: CXW, HIBB, DE, FL, EL, GPS, AMAT, ROST, VIAB, NKE & more at CNBC
07:41AM  These three stocks are working now: Pro
05:34AM  Allergan upgraded by Mizuho
Aug-18-16 05:35PM  Hedge Fund Confidence in Stocks Improves in Q2 (CHTR, MS) at Investopedia
08:00AM  Allergan to Present at 2016 Wells Fargo Healthcare Conference PR Newswire
Aug-17-16 05:29PM  Steve Mandel Buys Shire, Axes 6 Positions in 2nd Quarter
05:10PM  Allergan Features Prominently in Q2 2016 (AGN, PFE) at Investopedia
04:21PM  [$$] Four Picks for a Specialty Pharma Comeback at Barrons.com
02:58PM  Big Changes At The Top of Passport Capitals Portfolio As Yahoo (YHOO) Takes Top Spot at Insider Monkey
12:03PM  Billionaire Money Managers Sold off This Stock in the 2nd Quarter at Motley Fool
11:04AM  What Do Analysts Estimate for Merck?
09:04AM  Is Valeants Xifaxan Resuming Growth?
Aug-16-16 02:00PM  For Value Investors, Arbiter Partners Knows How to Pick 'Em
01:13PM  13F 2Q Wrap: Big Bets on Allergan; Buffett Buys Apple; Soros Sells Gold at Barrons.com
10:54AM  Will Allergan (AGN) Stock Be Helped as Icahn Makes New Bet on Shares?
10:25AM  Icahn Bets Big on Allergan; Trims PayPal Stake at Barrons.com
10:01AM  Credit Suisse Presents Bull And Bear Cases For Allergan
09:54AM  Icahn makes new bet on Allergan in Q2 -filing
09:33AM  Activist Carl Icahn Takes Stakes in Allergan, Herc Holdings, Slashes PayPal Position at Insider Monkey
Aug-15-16 05:52PM  Allergan Sees Action on 13F Deadline Day
04:39PM  Icahn makes new bet on Allergan, cuts Hertz in Q2 - filing
04:32PM  Icahn adds Allergan position; trims Hertz, PayPal stakes at MarketWatch
04:25PM  Hedge funds made big changes at drug companies in 2nd qtr -filings
04:05PM  David Tepper Raises Bet on Allergan, Adds 2 New Positions in Latest Quarter
01:22PM  Why is Time (TIME) Stock Popping Today?
01:05PM  Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis at 24/7 Wall St.
11:29AM  Why Allergan is Fine Without Large M&A
11:00AM  Billionaire David Teppers Biggest Q2 Moves Involve Western Digital, Facebook & Others at Insider Monkey
09:42AM  Appaloosa's Tepper Boosts Allergan Stake; Exits Delta And Facebook at Barrons.com
09:13AM  Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline
Aug-13-16 01:04PM  ALLERGAN PLC Financials
Aug-12-16 05:44PM  Third Point Takes New Stakes in Facebook, Energy Firms at The Wall Street Journal
05:01PM  David Tepper Goes Big on Allergan, Shies From S&P at The Wall Street Journal
Aug-11-16 07:14PM  Five Healthcare Stocks Billionaires Are Bullish On at Insider Monkey
05:41PM  Healthcare Growth Stocks in the S&P 500: Part 2
12:27PM  ETFs with exposure to Allergan Plc : August 11, 2016
11:30AM  Allergan Bought Itself an Exciting Opportunity in ForSight
11:16AM  Glaucoma Treatment Maker a $95M "Stepping Stone" for Allergan
09:31AM  Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox
09:15AM  Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox Accesswire
08:16AM  Allergan agrees to buy private biotech ForSight VISION5 for $95 mln at MarketWatch
08:00AM  Allergan to Acquire Eye Care Company ForSight VISION5 Adding Peri-Ocular Ring Technology to Company's Leading Portfolio of Innovative Eye Health Products PR Newswire
Aug-10-16 02:42PM  Dow going to 20,000?
12:04PM  Pfizers Business Segments and Their Performance
10:18AM  Allergan Plc :AGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
Aug-09-16 02:28PM  Allergan Narrowly Beats Earnings, Thanks to Sales Surge
12:08AM  [$$] Allergan Revenue Increases, Though Loss Widens at The Wall Street Journal
Aug-08-16 05:45PM  Allergan reports 2Q loss AAP
04:45PM  [$$] Allergan Selloff Makes for Great Buying Opportunity at Barrons.com
04:25PM  US STOCKS-Wall Street takes tiny step back from record highs
04:22PM  Allergan Stock Is 'Misunderstood'
04:09PM  Markets Right Now: Stocks closing lower on Wall Street
04:00PM  Allergan Earnings Top, But Stock Falls On Lowered Guidance
02:49PM  US STOCKS-Wall Street steps back from record highs
02:26PM  [$$] Allergan Revenue Increases, Though Loss Widens at The Wall Street Journal
02:10PM  These 7 Stocks Are Seeing Big Volume Today -- Here's How to Trade Them Now
01:45PM  Good, bad, & ugly: Murphy Oil, Allergan & more
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, and medical aesthetics, as well as dermatology and plastic surgery. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. Allergan plc also distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.